Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UB-421 + OBT in MDR HIV-1
NCT03164447Phase 2Unknown
- Sponsor
- United BioPharma
- Start
- Dec 2023
- Primary completion
- Mar 2024
- Modality
- IgG Antibodies
01
Overview
A Phase 2 trial of semzuvolimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by United BioPharma. Status: unknown.
02
Drugs
semzuvolimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03164447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03164447.